600161 天坛生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)7.24414.78111.92310.45812.092
总资产报酬率 ROA (%)5.05010.3088.1867.1897.950
投入资产回报率 ROIC (%)6.99314.19211.1659.61310.602

边际利润分析
销售毛利率 (%)43.81354.70050.76249.07647.529
营业利润率 (%)30.33142.40534.84233.60730.274
息税前利润/营业总收入 (%)30.17841.68433.76332.10928.619
净利润/营业总收入 (%)25.09435.01829.13828.27025.992

收益指标分析
经营活动净收益/利润总额(%)100.50998.70397.33694.96999.832
价值变动净收益/利润总额(%)1.9222.5102.0691.9720.967
营业外收支净额/利润总额(%)-0.511-0.415-0.356-0.410-0.313

偿债能力分析
流动比率 (X)6.0146.8935.9156.2829.321
速动比率 (X)3.0813.4393.6924.2676.672
资产负债率 (%)9.6908.42110.10512.17111.322
带息债务/全部投入资本 (%)2.0811.0483.6615.9676.975
股东权益/带息债务 (%)4,614.2089,261.1632,590.5861,547.2921,311.709
股东权益/负债合计 (%)714.730833.533685.127558.916614.298
利息保障倍数 (X)22,984.695-76.390-35.317-23.595-18.346

营运能力分析
应收账款周转天数 (天)40.0136.5911.7771.8200.969
存货周转天数 (天)425.302442.258365.297371.289360.057